271 related articles for article (PubMed ID: 33188902)
1. Functional reconstitution of HBV-specific CD8 T cells by in vitro polyphenol treatment in chronic hepatitis B.
Acerbi G; Montali I; Ferrigno GD; Barili V; Schivazappa S; Alfieri A; Laccabue D; Loglio A; Borghi M; Massari M; Rossi M; Vecchi A; Penna A; Boni C; Missale G; Lampertico P; Del Rio D; Ferrari C; Fisicaro P
J Hepatol; 2021 Apr; 74(4):783-793. PubMed ID: 33188902
[TBL] [Abstract][Full Text] [Related]
2. Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B.
Montali I; Ceccatelli Berti C; Morselli M; Acerbi G; Barili V; Pedrazzi G; Montanini B; Boni C; Alfieri A; Pesci M; Loglio A; Degasperi E; Borghi M; Perbellini R; Penna A; Laccabue D; Rossi M; Vecchi A; Tiezzi C; Reverberi V; Boarini C; Abbati G; Massari M; Lampertico P; Missale G; Ferrari C; Fisicaro P
J Hepatol; 2023 Jul; 79(1):50-60. PubMed ID: 36893853
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro.
Rossi M; Vecchi A; Tiezzi C; Barili V; Fisicaro P; Penna A; Montali I; Daffis S; Fletcher SP; Gaggar A; Medley J; Graupe M; Lad L; Loglio A; Soffredini R; Borghi M; Pollicino T; Musolino C; Alfieri A; Brillo F; Laccabue D; Massari M; Boarini C; Abbati G; Pedrazzi G; Missale G; Lampertico P; Ferrari C; Boni C
Gut; 2023 Nov; 72(11):2123-2137. PubMed ID: 36717219
[TBL] [Abstract][Full Text] [Related]
4. Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B.
Fisicaro P; Barili V; Montanini B; Acerbi G; Ferracin M; Guerrieri F; Salerno D; Boni C; Massari M; Cavallo MC; Grossi G; Giuberti T; Lampertico P; Missale G; Levrero M; Ottonello S; Ferrari C
Nat Med; 2017 Mar; 23(3):327-336. PubMed ID: 28165481
[TBL] [Abstract][Full Text] [Related]
5. CXCL13-mediated recruitment of intrahepatic CXCR5
Li Y; Tang L; Guo L; Chen C; Gu S; Zhou Y; Ye G; Li X; Wang W; Liao X; Wang Y; Peng X; Liu G; Zhang X; Sun J; Peng J; Hou J
J Hepatol; 2020 Mar; 72(3):420-430. PubMed ID: 31610223
[TBL] [Abstract][Full Text] [Related]
6. Enolase represents a metabolic checkpoint controlling the differential exhaustion programmes of hepatitis virus-specific CD8
Winkler F; Hipp AV; Ramirez C; Martin B; Villa M; Neuwirt E; Gorka O; Aerssens J; Johansson SE; Rana N; Llewellyn-Lacey S; Price DA; Panning M; Groß O; Pearce EL; Hermann CM; Schumann K; Hannibal L; Neumann-Haefelin C; Boettler T; Knolle P; Hofmann M; Wohlleber D; Thimme R; Bengsch B
Gut; 2023 Oct; 72(10):1971-1984. PubMed ID: 37541771
[TBL] [Abstract][Full Text] [Related]
7. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B.
Fisicaro P; Valdatta C; Massari M; Loggi E; Biasini E; Sacchelli L; Cavallo MC; Silini EM; Andreone P; Missale G; Ferrari C
Gastroenterology; 2010 Feb; 138(2):682-93, 693.e1-4. PubMed ID: 19800335
[TBL] [Abstract][Full Text] [Related]
8. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
[TBL] [Abstract][Full Text] [Related]
9. T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance.
Ye B; Liu X; Li X; Kong H; Tian L; Chen Y
Cell Death Dis; 2015 Mar; 6(3):e1694. PubMed ID: 25789969
[TBL] [Abstract][Full Text] [Related]
10.
Sung PS; Park DJ; Kim JH; Han JW; Lee EB; Lee GW; Nam HC; Jang JW; Bae SH; Choi JY; Shin EC; Park SH; Yoon SK
Front Immunol; 2019; 10():1319. PubMed ID: 31244857
[TBL] [Abstract][Full Text] [Related]
11. Augmentation of hepatitis B virus-specific cellular immunity with programmed death receptor-1/programmed death receptor-L1 blockade in hepatitis B virus and HIV/hepatitis B virus coinfected patients treated with adefovir.
Sherman AC; Trehanpati N; Daucher M; Davey RT; Masur H; Sarin SK; Kottilil S; Kohli A
AIDS Res Hum Retroviruses; 2013 Apr; 29(4):665-72. PubMed ID: 23259453
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B Virus-Specific CD8+ T Cells Maintain Functional Exhaustion after Antigen Reexposure in an Acute Activation Immune Environment.
Wang Q; Pan W; Liu Y; Luo J; Zhu D; Lu Y; Feng X; Yang X; Dittmer U; Lu M; Yang D; Liu J
Front Immunol; 2018; 9():219. PubMed ID: 29483916
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 21 Reinvigorates the Antiviral Activity of Hepatitis B Virus (HBV)-Specific CD8+ T Cells in Chronic HBV Infection.
Tang L; Chen C; Gao X; Zhang W; Yan X; Zhou Y; Guo L; Zheng X; Wang W; Yang F; Liu G; Sun J; Hou J; Li Y
J Infect Dis; 2019 Feb; 219(5):750-759. PubMed ID: 30260401
[TBL] [Abstract][Full Text] [Related]
14. Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV.
Fisicaro P; Valdatta C; Massari M; Loggi E; Ravanetti L; Urbani S; Giuberti T; Cavalli A; Vandelli C; Andreone P; Missale G; Ferrari C
Gastroenterology; 2012 Dec; 143(6):1576-1585.e4. PubMed ID: 22929808
[TBL] [Abstract][Full Text] [Related]
15. Hepatic expansion of virus-specific CD8
Wang H; Wu B; Li L; Hu L; Lin J; Jiang C; Cai G; Shen Q
Cell Immunol; 2017 Jan; 311():36-45. PubMed ID: 27743606
[TBL] [Abstract][Full Text] [Related]
16. [Effect of tenofovir disoproxil fumarate antiviral therapy on virus-specific CD8+T Cells function in patients with chronic hepatitis B].
Duan SP; Zhu LH; Hou LJ; Wang HW; Zhu XW; Hao J
Zhonghua Gan Zang Bing Za Zhi; 2021 May; 29(5):421-426. PubMed ID: 34107578
[No Abstract] [Full Text] [Related]
17. [Programmed death-1 (PD-1) and PD-L1 expression during antiviral treatment of chronic hepatitis B].
Xie DY; Lin BL; Chen FJ; Deng H; Chong YT; Zhang XH; Gao ZL
Zhonghua Gan Zang Bing Za Zhi; 2010 Sep; 18(9):646-50. PubMed ID: 20943073
[TBL] [Abstract][Full Text] [Related]
18. Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.
Boni C; Janssen HLA; Rossi M; Yoon SK; Vecchi A; Barili V; Yoshida EM; Trinh H; Rodell TC; Laccabue D; Alfieri A; Brillo F; Fisicaro P; Acerbi G; Pedrazzi G; Andreone P; Cursaro C; Margotti M; Santoro R; Piazzolla V; Brunetto MR; Coco B; Cavallone D; Zhao Y; Joshi A; Woo J; Lau AH; Gaggar A; Subramanian GM; Massetto B; Fung S; Ahn SH; Ma X; Mangia A; Ferrari C
Gastroenterology; 2019 Jul; 157(1):227-241.e7. PubMed ID: 30930022
[TBL] [Abstract][Full Text] [Related]
19. PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients.
Peng G; Li S; Wu W; Tan X; Chen Y; Chen Z
Mol Immunol; 2008 Feb; 45(4):963-70. PubMed ID: 17868872
[TBL] [Abstract][Full Text] [Related]
20. Programmed death-1 expression is associated with the disease status in hepatitis B virus infection.
Ye P; Weng ZH; Zhang SL; Zhang JA; Zhao L; Dong JH; Jie SH; Pang R; Wei RH
World J Gastroenterol; 2008 Jul; 14(28):4551-7. PubMed ID: 18680238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
